Abstract：
BACKGROUND:BCOR acts as a corepressor of BCL6, a potent oncogenic protein in cancers of the lymphoid lineage. We have found the recurrent somatic mutation of BCOR occurred in mature T-cell lymphoma (TCL). The role of BCOR mutation in lymphoid malignancies is unknown. METHODS:Lymphoma patient samples were analyzed to identify missense mutations in BCOR using Sanger sequencing. Transfection, RNA interference, immunoprecipitation, western blotting, cell proliferation, cytokine assays and quantitative real-time PCR were employed to determine the functional relevance of the novel K607E mutation in BCOR. The significant transcriptional changes were analyzed by performing DNA microarray profiling in cells expressing BCOR K607E mutant. RESULTS:One hundred thirty-seven lymphoma patient samples were analyzed to identify K607E mutation of the BCOR gene. The BCOR K607E mutation was identified in 15 of 47 NK/T cell lymphoma cases (31.9%), 2 of 18 angioimmunoblastic T-cell lymphoma cases (11.1%), 10 of 30 peripheral T-cell lymphoma, not otherwise specified cases (33.3%), and 13 of 42 diffuse large B-cell lymphoma cases (30.9%). Molecular analysis of BCOR K607E mutation revealed that compared to the wild-type BCOR, the mutant BCOR bound to the BCL6, PCGF1, and RING1B proteins with lesser affinity. Ectopic expression of BCOR K607E mutant significantly enhanced cell proliferation, AKT phosphorylation and the expression of interleukin-2 (IL-2) with up-regulated expression of HOX and S100 protein genes in T cells. BCOR silencing also significantly enhanced cell proliferation, AKT phosphorylation, and IL-2 production. CONCLUSIONS:Functional analyses indicated that K607E mutation of BCOR is oncogenic in nature and can serve as a genetic marker of T-cell lymphoma.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Kang JH,Lee SH,Lee J,Choi M,Cho J,Kim SJ,Kim WS,Ko YH,Yoo HYdoi
10.1186/s12885-021-07806-8subject
Has Abstractpub_date
2021-01-19 00:00:00pages
82issue
1issn
1471-2407pii
10.1186/s12885-021-07806-8journal_volume
21pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:High invasion and metastasis are the primary factors causing poor prognosis of patients with hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying these biological behaviors have not been completely elucidated. In this study, we investigate the molecular mechanism by which hypoxia prom...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-108
更新日期：2013-03-09 00:00:00
abstract：BACKGROUND:RECQL is a number of the RecQ DNA helicase family and plays an important role in maintaining genome stability. Although several studies have reported that RECQL mutations were correlated with the susceptibility to breast cancer, the effect on prognosis in breast cancer was not yet clarified. Here, we explore...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4585-1
更新日期：2018-06-18 00:00:00
abstract：BACKGROUND:Brain-derived neurotrophic factor (BDNF) has been reported to promote tumorigenesis and progression in several human malignancies. The purpose of this study was to explore the function of BDNF in lung squamous cell carcinoma (SCC) and adenocarcinoma (ADC). METHODS:The expression of BDNF was examined in 110 ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2218-0
更新日期：2016-02-29 00:00:00
abstract：BACKGROUND:To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular carcinoma (HCC) patients, and to explore the range of tumor sizes suita...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6237-5
更新日期：2019-10-22 00:00:00
abstract：BACKGROUND:Recurrence of colorectal cancer (CRC) may arise due to the persistence of drug-resistant and cancer-initiating cells that survive exposure to chemotherapy. Proteins responsible for this recurrence include the chemokine receptor CXCR4, which is known to enable CRC metastasis, as well as the cancer-initiating ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1702-2
更新日期：2015-11-10 00:00:00
abstract：BACKGROUND:Inhibition of DNA-binding of proteins by small-molecule chemicals holds immense potential in manipulating the activities of DNA-binding proteins. Such a chemical inhibition of DNA-binding of proteins can be used to modulate processes such as replication, transcription, DNA repair and maintenance of epigeneti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07526-5
更新日期：2020-10-20 00:00:00
abstract：BACKGROUND:Activating transcription factor-3 (ATF3) is involved in the complex process of cellular stress response. However, its exact role in cancer is discussed controversially because both tumor suppressive and oncogenic effects have been described. Here we followed-up on our previous observation that inhibition of ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-668
更新日期：2010-12-03 00:00:00
abstract：BACKGROUND:Genetic counselling and testing for Lynch syndrome (LS) have recently been introduced in several Latin America countries. We aimed to characterize the clinical, molecular and mismatch repair (MMR) variants spectrum of patients with suspected LS in Latin America. METHODS:Eleven LS hereditary cancer registrie...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3599-4
更新日期：2017-09-05 00:00:00
abstract：BACKGROUND:Gambogic acid (GA) is a major active ingredient of gamboge, a widely used traditional Chinese medicine that has been reported to be a potent cytotoxic agent against some malignant tumors. Many studies have shown that the NF-kappa B signaling pathway plays an important role in anti-apoptosis and the drug resi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-343
更新日期：2009-09-25 00:00:00
abstract：BACKGROUND:Tumor genotype plays a crucial role in clinical management of GIST. Whether genetic polymorphism of KIT may influence GIST patient outcome is unclear. METHODS:We investigated the biological and clinical significance of the presence of KIT exon 10 variant (c.1621 A > C), KIT (L541), in a transfected cell lin...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1817-5
更新日期：2015-10-24 00:00:00
abstract：INTRODUCTION:A functional polymorphism within MDM2, SNP309 T>G, has been linked to early onset cancer. This study examined clinical associations of breast cancer with SNP309 in a Scottish Caucasian population and investigated additional MDM2 intron 1 polymorphisms. METHODS:Intron 1 of MDM2 was PCR amplified and direct...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-281
更新日期：2008-10-01 00:00:00
abstract：BACKGROUND:Muscle invasive bladder cancer (MIBC) is often lethal and non-MIBC (NMIBC) can recur and progress, yet prognostic markers are currently inadequate. SAM68, a member of RNA-binding proteins, has been reported to contribute to progression of other cancers. The aim of this study is to investigate the potential u...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1367-x
更新日期：2015-05-06 00:00:00
abstract：BACKGROUND:In metastatic breast cancer (MBC), antigen profiles of metastatic tissue and primary tumor differ in up to 20 % of patients. Reassessment of predictive markers, including human epidermal growth factor receptor 2 (HER2) expression, might help to optimize MBC treatment. While tissue sampling is invasive and of...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1423-6
更新日期：2015-05-14 00:00:00
abstract：BACKGROUND:The increasing number of individuals living with cancer has led to a focus on the quality of life of survivors, and their families. Sexual wellbeing is a central component of quality of life, with a growing body of research demonstrating the association between cancer and changes to sexuality and intimacy. H...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-270
更新日期：2013-05-31 00:00:00
abstract：BACKGROUND:The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables such as primary tumour ...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/s12885-016-2345-7
更新日期：2016-05-12 00:00:00
abstract：BACKGROUND:FOXM1 regulates expression of cell cycle related genes that are essential for progression into DNA replication and mitosis. Consistent with its role in proliferation, elevated expression of FOXM1 has been reported in a variety of human tumour entities. FOXM1 is a gene of interest because recently chemical in...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-42
更新日期：2008-02-06 00:00:00
abstract：BACKGROUND:Clear cell renal cell carcinoma (ccRCC) accounts for more than 80% of the cases of renal cell carcinoma. In ccRCC deactivation of Von-Hippel-Lindau (VHL) gene contributes to the constitutive expression of hypoxia inducible factors 1 and 2 alpha (HIF-α), transcriptional regulators of several genes involved in...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-293
更新日期：2012-07-17 00:00:00
abstract：BACKGROUND:Of all female genital tract tumors, 1-3% are stromal malignancies. In 8-10% of cases, these are represented by Müllerian adenosarcoma an extremely rare tumor characterized by a stromal component of usually low-grade malignancy and by a benign glandular epithelial component. Variant that arises in the pouch o...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-171
更新日期：2011-05-15 00:00:00
abstract：BACKGROUND:Most staging systems for soft tissue sarcoma are based on histologic malignancy-grade, tumor size and tumor depth. These factors are generally dichotomized, size at 5 cm. We believe it is unlikely that tumor depth per se should influence a tumor's metastatic capability. Therefore we hypothesized that the unf...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-3-17
更新日期：2003-05-26 00:00:00
abstract：BACKGROUND:MicroRNA-148b (miR-148b) has been detected in various types of tumors, and is generally viewed as a tumor suppressor. Our previous study found the decreased expression of miR-148b in human non small cell lung cancer (NSCLC) specimens and cell lines. However, the underlying mechanisms of miR-148b in regulatin...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5400-3
更新日期：2019-03-08 00:00:00
abstract：BACKGROUND:To characterize prognostic and risk factors of central nervous system (CNS) metastases in patients with epithelial ovarian cancer (EOC). METHODS:A retrospective analysis of Xijing Hospital electronic medical records was conducted to identify patients with pathologically confirmed EOC and CNS metastases. In ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-829
更新日期：2014-11-17 00:00:00
abstract：BACKGROUND:The expression of HER2, estrogen (ER) and progesterone (PR) receptor can change during the course of the disease in breast cancer (BC). Therefore, reassessment of these markers at the time of disease progression might help to optimize treatment decisions. In this context, characterization of circulating tumo...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2587-4
更新日期：2016-07-25 00:00:00
abstract：BACKGROUND:The goal of this exploratory study was to develop and assess a prediction model which can potentially be used as a biomarker of breast cancer, based on anthropometric data and parameters which can be gathered in routine blood analysis. METHODS:For each of the 166 participants several clinical features were ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3877-1
更新日期：2018-01-04 00:00:00
abstract：BACKGROUND:It is known that amino acid oxidation is increased in tumor-bearing rat muscles and that leucine is an important ketogenic amino acid that provides energy to the skeletal muscle. METHODS:To evaluate the effects of a leucine supplemented diet on the intestinal absorption alterations produced by Walker 256, g...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-2-7
更新日期：2002-04-15 00:00:00
abstract：BACKGROUND:PRDM5 is an epigenetic regulator that has been recognized as an important tumour suppressor gene. Silencing of PRDM5 by promoter hypermethylation has been demonstrated in several cancer types and PRDM5 loss results in upregulation of the Wnt pathway and increased cellular proliferation. PRDM5 has not been ex...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1011-9
更新日期：2015-01-23 00:00:00
abstract：BACKGROUND:Resistance to 5-fluorouracil (5-FU) in patients with colorectal cancer prevents effective treatment and leads to unnecessary and burdensome chemotherapy. Therefore, prediction of 5-FU resistance is imperative. METHODS:To identify the proteins linked to 5-FU resistance, two-dimensional gel electrophoresis-ba...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-160
更新日期：2014-03-06 00:00:00
abstract：BACKGROUND:Omega-3 polyunsaturated fatty acids (PUFAs) were proposed to have potential effects against inflammation and cancer. However, results from epidemiology studies remain inconsistent. We aimed to explore the associations of plasma PUFAs with EC recurrence and all-cause mortality. METHOD:Women diagnosed with en...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07035-5
更新日期：2020-06-20 00:00:00
abstract：BACKGROUND:HOXA family genes were crucial transcription factors involving cell proliferation and apoptosis. While few studies have focused on HOXA10 in AML. We aimed to investigate the prognostic significance of HOXA10. METHODS:We downloaded datasets from GEO and BeatAML database, to compare HOXA expression level betw...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07088-6
更新日期：2020-06-22 00:00:00
abstract：BACKGROUND:Axillary lymph node (ALN) status is an important prognostic factor for breast cancer. We retrospectively used contrast-enhanced computed tomography (CE-CT) to evaluate the presence of ALN, metastasis based on size, shape, and contrasting effects. METHODS:Of 131 consecutive patients who underwent CE-CT follo...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-730
更新日期：2014-09-30 00:00:00
abstract：BACKGROUND:Less than 1% of all breast cancer cases are found in men, who reportedly have inferior outcomes compared with matched women patients. Ethnic differences may also affect their prognosis. Here, we investigated overall survival (OS) and major prognostic factors for male breast cancer (MBC) in a cohort of Egypti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-227
更新日期：2014-03-28 00:00:00
